Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Scientific Reports
|
August 10, 2016
Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay
Yisu Li, Binbin Guo, Zhijian Xu, et al.
Journal of Chemical Information and Modeling
|
September 30, 2011
Computational screening for active compounds targeting protein sequences: methodology and experimental validation
Fei Wang, Dongxiang Liu, Heyao Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 4, 2012
Combining pharmacophore, docking and substructure search approaches to identify and optimize novel B-RafV600E inhibitors
Zhijian Xu, Guirui Yan, Gaihong Wang, et al.
European Journal of Medicinal Chemistry
|
December 3, 2014
Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination
Haiyan Cai, Qiufeng Liu, Dingding Gao, et al.
Journal of Medicinal Chemistry
|
September 3, 2014
Design, synthesis, and structure-activity and structure-pharmacokinetic relationship studies of novel [6,6,5] tricyclic fused oxazolidinones leading to the discovery of a potent, selective, and orally bioavailable FXa inhibitor
Tao Xue, Shi Ding, Bin Guo, et al.
Archiv Der Pharmazie
|
April 15, 2015
Design, synthesis, and pharmacological evaluation of highly potent and selective dipeptidyl peptidase-4 inhibitors
Tao Jiang, Yuren Zhou, Jianming Zhu, et al.
The Journal of Endocrinology
|
November 8, 2018
Vincamine as a GPR40 agonist improves glucose homeostasis in type 2 diabetic mice
Te Du, Liu Yang, Xu Xu, et al.
ACS Medicinal Chemistry Letters
|
May 26, 2015
Design, Synthesis, and Pharmacological Evaluation of Fused β-Homophenylalanine Derivatives as Potent DPP-4 Inhibitors
Tao Jiang, Yuren Zhou, Zhuxi Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 29, 2024
Slow Metabolism-Driven Amplification of Hepatic PPARγ Agonism Mediates Benzbromarone-Induced Obesity-Specific Liver Injury
Guanting Li, Yourong Hu, Han Zhao, et al.
Oncotarget
|
January 16, 2017
Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose
Dandan Yin, Xuyang Xia, Junlong Zhang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Scientific Reports
|
August 10, 2016
Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay
Yisu Li, Binbin Guo, Zhijian Xu, et al.
Journal of Chemical Information and Modeling
|
September 30, 2011
Computational screening for active compounds targeting protein sequences: methodology and experimental validation
Fei Wang, Dongxiang Liu, Heyao Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 4, 2012
Combining pharmacophore, docking and substructure search approaches to identify and optimize novel B-RafV600E inhibitors
Zhijian Xu, Guirui Yan, Gaihong Wang, et al.
European Journal of Medicinal Chemistry
|
December 3, 2014
Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination
Haiyan Cai, Qiufeng Liu, Dingding Gao, et al.
Journal of Medicinal Chemistry
|
September 3, 2014
Design, synthesis, and structure-activity and structure-pharmacokinetic relationship studies of novel [6,6,5] tricyclic fused oxazolidinones leading to the discovery of a potent, selective, and orally bioavailable FXa inhibitor
Tao Xue, Shi Ding, Bin Guo, et al.
Archiv Der Pharmazie
|
April 15, 2015
Design, synthesis, and pharmacological evaluation of highly potent and selective dipeptidyl peptidase-4 inhibitors
Tao Jiang, Yuren Zhou, Jianming Zhu, et al.
The Journal of Endocrinology
|
November 8, 2018
Vincamine as a GPR40 agonist improves glucose homeostasis in type 2 diabetic mice
Te Du, Liu Yang, Xu Xu, et al.
ACS Medicinal Chemistry Letters
|
May 26, 2015
Design, Synthesis, and Pharmacological Evaluation of Fused β-Homophenylalanine Derivatives as Potent DPP-4 Inhibitors
Tao Jiang, Yuren Zhou, Zhuxi Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 29, 2024
Slow Metabolism-Driven Amplification of Hepatic PPARγ Agonism Mediates Benzbromarone-Induced Obesity-Specific Liver Injury
Guanting Li, Yourong Hu, Han Zhao, et al.
Oncotarget
|
January 16, 2017
Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose
Dandan Yin, Xuyang Xia, Junlong Zhang, et al.
Page
of 5